RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | liver cirrhosis |
|
Accession: | DOID:5082
|
browse the term
|
Definition: | Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. |
Synonyms: | exact_synonym: | Hepatic Cirrhosis; Hepatic Fibrosis; cirrhosis; cirrhosis of liver; hepatic cirrhoses; liver cirrhoses; liver fibroses; liver fibrosis |
| primary_id: | MESH:D008103 |
| xref: | EFO:0001422; ICD10CM:K74.60; NCI:C2951 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
associated with Hepatitis C, Chronic;DNA:SNP:cds:1331T>C, p.V444A,(rs2287622)(human) |
RGD |
PMID:29755014 |
RGD:14402415 |
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
severity susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism associated with cholestasis;DNA:mutations: : associated with cystic fibrosis;DNA:SNP:exon:c.504T>C(human) |
CTD RGD |
PMID:8698195 PMID:18221819 PMID:18482588 PMID:19467940 |
RGD:14694975, RGD:4889446 |
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Ace |
angiotensin I converting enzyme |
treatment severity no_association |
IEP ISO |
associated with Chronic Hepatitis B;protein:increased expression:blood serum (human) associated with hepatitis C;DNA:insertion/deletion: associated with liver disease;DNA:insertion/deletion: |
RGD |
PMID:29335866 PMID:29085215 PMID:19456900 PMID:26681055 PMID:28822808 |
RGD:25671453, RGD:40400898, RGD:39939123, RGD:11537135, RGD:25671454 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24239723 PMID:24321339 PMID:30097701 PMID:32659284 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
severity |
ISO |
protein:increased expression, increased activity:liver (rat) |
RGD |
PMID:16689760 |
RGD:1598737 |
NCBI chr 3:10,299,264...10,338,464
Ensembl chr 3:10,300,028...10,346,687
|
|
G |
Adar |
adenosine deaminase, RNA-specific |
ameliorates |
ISO |
associated with human immunodeficiency virus infectious disease, hepatitis C;DNA:SNPs:exon 2, 3' utr:multiple (human) |
RGD |
PMID:29018269 |
RGD:125097516 |
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:16115302 |
RGD:5686674 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:17006986 |
RGD:1599139 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16782692 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
mRNA:decreased expression:lung (liver) |
RGD |
PMID:22669512 |
RGD:7245533 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agt |
angiotensinogen |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15613622 PMID:21873937 |
RGD:8549465 |
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29416063 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
IEP |
mRNA,protein:increased expression:liver |
RGD |
PMID:23925424 |
RGD:14348971 |
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:decreased activity:liver (human) |
CTD RGD |
PMID:25226513 PMID:6848403 |
RGD:15042852 |
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
associated with Head and Neck Neoplasms; CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17977396 PMID:21851314 PMID:23285146 |
RGD:11035282 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23793029 |
|
NCBI chr 5:61,309,183...61,350,596
Ensembl chr 5:61,309,183...61,350,596
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum (human) |
RGD |
PMID:27106140 |
RGD:25671439 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22271822 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arrb1 |
arrestin, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33549628 |
|
NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36526012 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Axin1 |
axin 1 |
|
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:31514071 |
RGD:150530482 |
NCBI chr10:15,163,684...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO IEP |
associated with hepatocellular carcinoma;protein:decreased expression:liver: mRNA:decreased expression:liver |
RGD |
PMID:22625427 PMID:26902423 |
RGD:153350130, RGD:153350133 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azin1 |
antizyme inhibitor 1 |
|
ISO |
associated with hepatitis B;DNA SNP: :rs2679757 (human) associated with hepatocellular carcinoma;RNA:increased editing:liver |
RGD |
PMID:21586232 PMID:23291631 |
RGD:14700702, RGD:14700705 |
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30097701 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:22895779 |
RGD:11561934 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
C1qb |
complement C1q B chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C5 |
complement C5 |
disease_progression |
ISO |
associated with Hepatitis C, Chronic;DNA:SNPs: :rs17611, rs2300929 (human) |
RGD |
PMID:15995705 |
RGD:1600592 |
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp3 |
caspase 3 |
|
ISO |
associated with cholestasis |
RGD |
PMID:29105510 |
RGD:13782297 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
associated with cholestasis |
RGD |
PMID:29105510 |
RGD:13782297 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
|
ISO |
associated with cholestasis |
RGD |
PMID:29105510 |
RGD:13782297 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20697377 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
severity treatment |
ISO |
DNA:SNAP, haplotype: :rs11652536(human) |
RGD |
PMID:28011329 PMID:20978355 PMID:28011329 |
RGD:14995306, RGD:14995328, RGD:14995306 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
ameliorates |
ISO IMP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16652398 PMID:17657819 PMID:26396155 PMID:36469291 PMID:36469291 PMID:26946098 More...
|
RGD:243048439, RGD:243048439, RGD:40925947 |
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
associated with hepatitis B;mRNA:decreased expression:Peripheral Blood Mononuclear Cell |
RGD |
PMID:33320844 |
RGD:151664743 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
associated with Fatty Liver |
RGD |
PMID:19280268 |
RGD:5688143 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20353583 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd163 |
CD163 molecule |
exacerbates |
ISO |
associated with Chronic Hepatitis B, Chronic Hepatitis C;protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human) |
RGD |
PMID:24623375 PMID:26339412 |
RGD:127285681, RGD:11251207 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
associated with Hypertension, Portal |
RGD |
PMID:22648712 |
RGD:6893541 |
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd9 |
CD9 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32659284 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cenpc |
centromere protein C |
|
ISO |
associated with Anticentromere antibody positivity |
RGD |
PMID:25220385 |
RGD:27372886 |
NCBI chr14:21,988,067...22,046,732
Ensembl chr14:21,988,144...22,055,476
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Cldn1 |
claudin 1 |
severity |
IEP |
associated with hepatitis C, Chronic;mRNA,protein:increased expression:liver (human) |
RGD |
PMID:21620107 |
RGD:26884347 |
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11433348 PMID:21863215 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15765409 |
|
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21863215 PMID:24239723 PMID:24321339 PMID:26396155 PMID:32659284 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1880254 PMID:2566230 PMID:11167689 PMID:15787813 PMID:16679477 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17919502 |
|
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:26396155 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
ISO |
associated with Hepatitis C, Chronic; protein:increased expression:liver |
RGD |
PMID:26627607 |
RGD:11528851 |
NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760
|
|
G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
|
ISO |
associated with Hepatitis C, Chronic; protein:increased expression:liver |
RGD |
PMID:26627607 |
RGD:11528851 |
NCBI chr10:15,717,794...15,780,482
Ensembl chr10:15,717,794...15,780,603
|
|
G |
Crp |
C-reactive protein |
|
ISO |
associated with Hepatitis C, Chronic;protein:decreased expression:serum |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
exacerbates |
ISO |
associated with hepatitis C, liver cirrhosis;protein:increased expression:serum (human) |
RGD |
PMID:26437001 |
RGD:11079330 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21047994 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
severity disease_progression |
ISO |
mRNA:increased expression:liver associated with Chronic Hepatitis B; |
RGD |
PMID:11418676 PMID:28067328 PMID:29105936 |
RGD:27095892, RGD:27095955, RGD:27095953 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33069761 |
|
NCBI chr17:8,317,933...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cygb |
cytoglobin |
|
IMP IEP |
|
RGD |
PMID:16581302 PMID:11320098 |
RGD:9685176, RGD:68672 |
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27565560 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24381012 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2r1 |
cytochrome P450, family 2, subfamily r, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24381012 |
|
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
treatment |
ISO |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18000880 |
RGD:10400849 |
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24381012 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:24211420 |
RGD:9588224 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:20628429 |
RGD:4144843 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egfr |
epidermal growth factor receptor |
severity |
ISO |
associated with non-alcoholic fatty liver disease;protein:increased expression:plasma |
RGD |
PMID:28650518 |
RGD:14401722 |
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
|
IEP |
protein:increased expression:liver, nucleus |
RGD |
PMID:22292946 |
RGD:10395298 |
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eln |
elastin |
severity |
IEP |
protein:increased expression:liver: |
RGD |
PMID:22223197 |
RGD:9585666 |
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
ISO |
associated with hepatitis C |
RGD |
PMID:15651265 |
RGD:9685530 |
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Ephb2 |
Eph receptor B2 |
ameliorates |
ISO |
associated with malaria; |
RGD |
PMID:25784101 |
RGD:127285023 |
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
F2 |
coagulation factor II |
severity |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased activity:plasma (human) protein:decreased expression:plasma (human) protein:increased expression:plasma (human) |
CTD RGD |
PMID:10216089 PMID:15726661 PMID:29768734 PMID:9863491 |
RGD:14985236, RGD:14985235, RGD:14401592 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21037076 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F3 |
coagulation factor III, tissue factor |
severity treatment |
ISO |
mRNA, protein:increased expression, increased activity:monocyte (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10216089 PMID:21037076 PMID:9863491 PMID:15946135 PMID:28883694 |
RGD:11341737, RGD:14401592, RGD:14401577, RGD:14401724 |
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
F5 |
coagulation factor V |
disease_progression susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18485088 PMID:10520855 PMID:26226452 |
RGD:14700663, RGD:14700659 |
NCBI chr13:76,513,463...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
|
IMP |
|
RGD |
PMID:27510266 |
RGD:14398823 |
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fahem15Dlli-/- |
fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli |
|
IMP |
after NTBC withdrawal in the drinking water |
RGD |
PMID:27510266 |
RGD:14398823 |
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase subunit beta |
|
ISO |
ClinVar Annotator: match by term: Liver cirrhosis |
ClinVar |
PMID:29979980 |
|
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26396155 PMID:14661032 |
RGD:12910489 |
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28673684 |
|
NCBI chr 1:200,056,656...200,059,944
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17093919 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17692400 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17692400 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
ISO |
associated with hepatocellular carcinoma; DNA:SNP:cds: p.G388R (rs351855) (human) |
RGD |
PMID:25860955 |
RGD:11057080 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
IEP ISO |
mRNA:increased expressin:liver: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11981751 PMID:11981751 |
RGD:634296 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Focad |
focadhesin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35864190 |
|
NCBI chr 5:102,564,560...102,886,587
Ensembl chr 5:102,564,598...102,886,582
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33372984 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
associated with Chronic Hepatitis C;mRNA:increased expression:liver (human) |
RGD |
PMID:25995247 |
RGD:151361196 |
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24381012 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
IMP |
|
RGD |
PMID:22942279 |
RGD:11049542 |
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdf1 |
growth differentiation factor 1 |
disease_progression |
ISO |
associated with Stable Angina; protein:decreased expression:blood plasma (human) |
RGD |
PMID:36268984 |
RGD:243065147 |
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
disease_progression severity |
ISO |
associated with Hepatitis B, Chronic; |
RGD |
PMID:27793641 PMID:25254524 PMID:15997630 |
RGD:14701041, RGD:14747031, RGD:14747030 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gli3 |
GLI family zinc finger 3 |
|
ISO |
mRNA:increased expression:serum: |
RGD |
PMID:32319630 |
RGD:155791681 |
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Gp1ba |
glycoprotein Ib platelet subunit alpha |
treatment |
ISO |
|
RGD |
PMID:31851564 |
RGD:42722628 |
NCBI chr10:55,352,938...55,355,804
Ensembl chr10:55,352,899...55,356,774
|
|
G |
Gpc3 |
glypican 3 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:28801286 |
RGD:243065135 |
NCBI chr X:131,868,983...132,236,837
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
severity |
ISO |
associated with Hepatitis B, Chronic; |
RGD |
PMID:30665287 |
RGD:14975252 |
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
ISO |
associated with hepatitis B;protein:increased expression:mesenteric artery (human) |
RGD |
PMID:23742775 |
RGD:13792718 |
NCBI chr 1:201,581,480...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
IEP ISO |
protein:decreased expression:liver (rat) associated with Hepatitis C, Chronic |
RGD |
PMID:20141739 PMID:26548378 |
RGD:7771534, RGD:11097429 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
associated with Hepatitis C, Chronic |
RGD |
PMID:26548378 |
RGD:11097429 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27396813 |
|
NCBI chr20:40,548,250...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hfe |
homeostatic iron regulator |
|
ISO |
DNA:missense mutations: :p.H63D, p.C282Y (human) |
RGD |
PMID:27816425 |
RGD:14701047 |
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17097021 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hhip |
Hedgehog-interacting protein |
|
ISO |
mRNA:decreased expression:liver: |
RGD |
PMID:19815628 |
RGD:11552602 |
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36126797 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
ISO |
protein:decreased expression:liver: |
RGD |
PMID:20876809 |
RGD:12904747 |
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hp |
haptoglobin |
|
ISO |
associated with Hepatitis C, Chronic;protein:decreased expression:serum |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:7535324 |
RGD:14694815 |
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15199296 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
susceptibility |
ISO |
associated with Hepatitis B, Chronic;DNA:missense mutations, haplotype:cds:p.G241R, p.K469E (human) |
RGD |
PMID:18233990 |
RGD:14402042 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18665156 |
|
NCBI chr 5:103,095,767...103,098,260
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
|
ISO |
|
RGD |
PMID:21664391 PMID:12389079 |
RGD:6893452, RGD:10755749 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifnl3 |
interferon, lambda 3 |
treatment |
ISO |
associated with Hepatitis C;DNA:SNP: :rs8099917 (human) |
RGD |
PMID:23145809 |
RGD:11528558 |
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
susceptibility |
ISO |
associated with Hepatis B virus;DNA:SNP:3'UTR:rs3743251(human) |
RGD |
PMID:24758241 |
RGD:14985227 |
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
severity |
ISO |
associated with non-alcoholic fatty liver disease;protein:decreased expression:plasma |
RGD |
PMID:28650518 |
RGD:14401722 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il10 |
interleukin 10 |
severity no_association |
ISO |
associated with Hepatitis C, Chronic;DNA:SNP:promoter:-592C>A (human) DNA:SNP:promoter:-592C>A (rs1800872) (human) DNA:SNP:promoter:-1082G>A (rs1800896) (human) associated with Hepatitis C, Chronic;DNA:SNP:promoter:-1082 G>A (human) |
RGD |
PMID:27660094 PMID:26909998 PMID:26909998 PMID:27660094 |
RGD:14975134, RGD:14975152, RGD:14975152, RGD:14975134 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
severity |
ISO |
protein:increased expression:plasma: associated with Hepatitis C, Chronic;mRNA:increased expression:PBMC: |
RGD |
PMID:12462332 PMID:19740312 PMID:19740312 |
RGD:14695542, RGD:14696656, RGD:14696656 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18bp |
interleukin 18 binding protein |
disease_progression |
ISO |
protein:increased expression:plasma: |
RGD |
PMID:12462332 |
RGD:14695542 |
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
severity |
ISO |
associated with Schistosomiasis Japonica |
RGD |
PMID:31200771 |
RGD:39938956 |
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
associated with sclerosing cholangitis |
RGD |
PMID:29698570 |
RGD:14928214 |
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il21 |
interleukin 21 |
exacerbates |
ISO |
associated with Chronic Hepatitis B;mRNA:increased expression: liver (human) |
RGD |
PMID:24611989 |
RGD:127285546 |
NCBI chr 2:120,119,598...120,126,941
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
associated with hepatitis B;protein:increased expression:blood serum (human) |
RGD |
PMID:22230324 |
RGD:126790507 |
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Il33 |
interleukin 33 |
severity |
ISO |
associated with Schistosomiasis Japonica |
RGD |
PMID:31200771 PMID:31053540 |
RGD:39938956, RGD:40400690 |
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12830005 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf5 |
interferon regulatory factor 5 |
severity |
ISO |
|
RGD |
PMID:27942586 PMID:27942586 |
RGD:40924562, RGD:40924562 |
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Itgb6 |
integrin subunit beta 6 |
disease_progression |
ISO |
associated with Hepatitis C, Chronic;mRNA:increased expression:liver |
RGD |
PMID:18221819 |
RGD:2302245 |
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
associated with hepatitis B;protein:increased expression:serum |
RGD |
PMID:24836184 |
RGD:40903002 |
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jak1 |
Janus kinase 1 |
treatment |
ISO |
associated with Schistosomiasis Japonica |
RGD |
PMID:27439782 |
RGD:19165137 |
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
severity |
IEP |
mRNA:increased expression:liver (human) |
RGD |
PMID:26385087 |
RGD:18337263 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17133482 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kdr |
kinase insert domain receptor |
disease_progression |
ISO |
associated with Chronic Hepatitis |
RGD |
PMID:27323788 |
RGD:126908000 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Klf5 |
KLF transcription factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33549628 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Klkb1 |
kallikrein B1 |
|
IEP |
|
RGD |
PMID:14986822 |
RGD:7297050 |
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
|
|
G |
Krt18 |
keratin 18 |
severity |
ISO |
protein:increased expression: serum (human) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:20538000 PMID:9011570 PMID:29023872 |
RGD:1624318, RGD:18337484 |
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
protein:increased phosphorylation:liver (human) CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:20538000 PMID:11372009 PMID:15368451 |
RGD:1600062, RGD:14401583 |
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr13:65,284,664...65,344,200
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:17918268 |
RGD:2292126 |
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36108984 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lgals1 |
galectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
|
RGD |
PMID:16549783 |
RGD:9685224 |
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals3bp |
galectin 3 binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lox |
lysyl oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr18:45,964,311...46,041,477
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30097701 |
|
NCBI chr 8:58,692,592...58,716,356
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lum |
lumican |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:22895779 |
RGD:11561934 |
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
exacerbates |
ISO |
|
RGD |
PMID:23271722 |
RGD:151665348 |
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mbl2 |
mannose binding lectin 2 |
severity susceptibility |
ISO |
associated with hepatitis C; DNA:haplotype:promoter, exon: associated with hepatitis B;DNA:SNP:exon: |
RGD |
PMID:20570631 PMID:26857650 |
RGD:14696832, RGD:14696836 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mgll |
monoglyceride lipase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30301768 |
|
NCBI chr 4:121,192,187...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32659284 |
|
NCBI chr 1:166,345,853...166,471,715 NCBI chr 1:166,491,721...166,530,575
Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
mRNA:decreased expression:blood (human) |
RGD |
PMID:27528885 |
RGD:151361113 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir145 |
microRNA 145 |
|
IEP |
miRNA:decreased expression:liver (human) |
RGD |
PMID:27289031 |
RGD:15039397 |
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir146a |
microRNA 146a |
exacerbates |
ISO |
associated with hepatitis B;miRNA:increased expression:liver (human) associated with hepatitis B; miRNA:decreased expression: liver, peripheral blood mononuclear cell, blood serum (human) |
RGD |
PMID:25805734 PMID:31086599 |
RGD:126925149, RGD:126925162 |
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir152 |
microRNA 152 |
|
ISO |
miRNA:decreased expression:serum |
RGD |
PMID:31258681 |
RGD:19165153 |
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
|
|
G |
Mir153 |
microRNA 153 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 6:138,163,595...138,163,681
Ensembl chr 6:138,163,595...138,163,681
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:29420849 |
RGD:21409750 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
associated with hepatocellular carcinoma; RNA:decreased expression:liver (human) |
RGD |
PMID:24330766 |
RGD:153344567 |
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir200a |
microRNA 200a |
|
IEP |
RNA:decreased expression:liver: |
RGD |
PMID:32319630 |
RGD:155791681 |
NCBI chr 5:166,648,494...166,648,582
|
|
G |
Mir200b |
microRNA 200b |
treatment |
ISO |
associated with primary sclerosing cholangitis; |
RGD |
PMID:28634212 |
RGD:14928323 |
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
|
|
G |
Mir21 |
microRNA 21 |
onset treatment disease_progression ameliorates |
IEP ISO |
associated with nonalcoholic fatty liver disease;miRNA:increased expression:liver, plasma associated with chronic hepatitis B |
RGD |
PMID:27320964 PMID:30419452 PMID:30147020 PMID:20625373 PMID:26946098 |
RGD:14695024, RGD:41404717, RGD:41404701, RGD:41404667, RGD:40925947 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir221 |
microRNA 221 |
|
ISO |
RNA:increased expression:liver |
RGD |
PMID:22267590 |
RGD:151709001 |
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
|
|
G |
Mir222 |
microRNA 222 |
|
ISO |
RNA:increased expression:liver |
RGD |
PMID:22267590 |
RGD:151709001 |
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
|
|
G |
Mir223 |
microRNA 223 |
severity |
ISO |
associated with Chronic Hepatitis C; associated with Chronic Hepatitis B; RNA:decreased expression:serum: associated with Chronic HepatitisC; RNA:decreased expression:serum: RNA:altered expression:serum,liver |
RGD |
PMID:28211229 PMID:24595450 PMID:25391771 PMID:28646120 |
RGD:21408569, RGD:21408583, RGD:21408580, RGD:21408574 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
RNA:decreased expression:liver |
RGD |
PMID:29587268 |
RGD:35673290 |
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
|
|
G |
Mir30b |
microRNA 30b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
|
|
G |
Mir30c1 |
microRNA 30c-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 5:134,349,237...134,349,325
Ensembl chr 5:134,349,237...134,349,325
|
|
G |
Mir30c2 |
microRNA 30c-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 9:25,757,342...25,757,425
Ensembl chr 9:25,757,342...25,757,425
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:36126797 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
|
|
G |
Mir3545 |
microRNA 3545 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32659284 |
|
NCBI chr 6:131,199,542...131,199,656
Ensembl chr 6:131,199,542...131,199,656
|
|
G |
Mir503 |
microRNA 503 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr X:132,806,303...132,806,373
Ensembl chr X:132,806,303...132,806,373
|
|
G |
Mir764 |
microRNA 764 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr X:110,678,597...110,678,704
Ensembl chr X:110,678,597...110,678,704
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
severity |
IDA IEP |
protein:decreased expression:serum (rat) |
RGD |
PMID:16124044 PMID:14606082 |
RGD:7207132, RGD:7207396 |
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
ISO |
|
RGD |
PMID:21382168 |
RGD:7207361 |
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15763341 PMID:26396155 PMID:23411180 |
RGD:8657103 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mpo |
myeloperoxidase |
disease_progression |
ISO |
DNA:SNP:promoter:-463G>A( rs2333227)(human) |
RGD |
PMID:19731237 |
RGD:26923907 |
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNP: :677C>T(human) |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
IEP |
mRNA:increased expression:ileum |
RGD |
PMID:22172882 |
RGD:7349362 |
NCBI chr 1:196,796,257...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Muc3 |
mucin 3 |
|
IEP |
mRNA:increased expression:ileum |
RGD |
PMID:22172882 |
RGD:7349362 |
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:23770341 |
RGD:14695015 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
IDA ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:23793039 PMID:22732220 |
RGD:10412731 |
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP IDA |
protein:decreased activity:liver (rat) |
RGD |
PMID:10535886 PMID:12759254 |
RGD:7775034, RGD:7794774 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22216111 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15613622 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
severity |
ISO |
protein:increased expression:plasma: |
RGD |
PMID:9350073 PMID:23940514 |
RGD:7246914, RGD:7248670 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IDA |
|
RGD |
PMID:29078262 |
RGD:13442479 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
treatment severity |
IEP ISO |
mRNA:altered expression:liver, kidney (rat) mRNA:altered expression:liver (mouse) |
RGD |
PMID:30308196 PMID:19418582 |
RGD:15042865, RGD:15042868 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32721574 |
|
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
associated with Hepatitis B;mRNA:decreased expression:blood, mononuclear cell |
RGD |
PMID:25755481 |
RGD:11073733 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA: increased expression |
RGD |
PMID:22539040 PMID:22407906 |
RGD:6482830, RGD:6482858 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
IEP |
mRNA,protein:increased expression:liver: |
RGD |
PMID:17397961 |
RGD:9854631 |
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
severity |
ISO IEP |
protein:decreased expression:liver: |
RGD |
PMID:24562544 PMID:24562544 |
RGD:9999176, RGD:9999176 |
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:increased expression:blood microparticle (human) |
RGD |
PMID:22465620 |
RGD:6771231 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29416063 |
|
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Pgf |
placental growth factor |
|
ISO |
mRNA, protein:increased expression:liver, serum |
RGD |
PMID:21520176 |
RGD:6483607 |
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Phkg2 |
phosphorylase kinase catalytic subunit gamma 2 |
|
ISO |
DNA:missense mutation, nonsense mutation (human) |
RGD |
PMID:9384616 |
RGD:737725 |
NCBI chr 1:182,184,362...182,197,124
Ensembl chr 1:182,184,650...182,197,124
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
treatment |
IMP |
associated with Schistosomiasis Japonica |
RGD |
PMID:29323718 |
RGD:38599216 |
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
DNA:deletion:exon: |
RGD |
PMID:17519956 |
RGD:14700917 |
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18481824 PMID:26396155 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:22098627 |
RGD:6484116 |
NCBI chr 1:80,053,441...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
severity disease_progression |
ISO |
associated with non-alcoholic fatty liver disease:DNA:SNP: :rs738409 (p.I148M) (human) associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human) associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human) |
RGD |
PMID:20648474 PMID:31377187 PMID:29674183 |
RGD:14981584, RGD:14981594, RGD:14981591 |
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32344006 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with schistosomiasis;protein, mRNA:decreased expression:liver (mouse) |
CTD RGD |
PMID:26023714 PMID:31907686 |
RGD:127285596 |
NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:29109031 |
RGD:14695008 |
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptn |
pleiotrophin |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:18381592 |
RGD:9834946 |
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
treatment |
IDA |
|
RGD |
PMID:21893185 |
RGD:9831391 |
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G |
Reg3b |
regenerating family member 3 beta |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:10550309 |
RGD:9831380 |
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Reln |
reelin |
|
ISO |
protein:altered expression:plasma (human) |
RGD |
PMID:18449964 |
RGD:2317777 |
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15613622 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rgn |
regucalcin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
|
IEP |
|
RGD |
PMID:19003918 |
RGD:10449440 |
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
associated with Hepatitis C, Chronic;DNA:SNPs: :rs910049, rs3135363(human) associated with hepatitis B;DNA:polymorphism: :HLA-DQA1*0104 (human) |
RGD |
PMID:23321320 PMID:17845309 |
RGD:14401563, RGD:126925986 |
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
associated with Schistosomiasis Japonica;DNA:polymorphisms: :HLA-DQB1*0303, HLA-DQB1*0601, HLA-DQB1*0609(human) |
RGD |
PMID:11336748 |
RGD:36049755 |
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
associated with Schistosomiasis Japonica;DNA:polymorphisms: :HLA-DRB1*0901, HLA-DRB1*1302, HLA-DRB1*1501(human) |
RGD |
PMID:11336748 |
RGD:36049755 |
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
RT1-Ha |
RT1 class II, locus Ha |
severity |
ISO |
DAN:polymorphism: : |
RGD |
PMID:10203020 |
RGD:14694972 |
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:3485248 PMID:20511674 PMID:25579632 PMID:20522742 |
RGD:14695525 |
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Serpina6 |
serpin family A member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Serpinh1 |
serpin family H member 1 |
disease_progression treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica associated with Schistosomiasis Japonica;mRNA:increased expression:liver (human) associated with schistosomiasis;mRNA:increased expression:liver (human) |
CTD RGD |
PMID:24321339 PMID:31612672 PMID:32410640 PMID:24295791 PMID:24295791 PMID:25111595 More...
|
RGD:41412161, RGD:41410785, RGD:41410784, RGD:41410784, RGD:41410780 |
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
|
|
G |
Shc1 |
SHC adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32659284 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
|
|
G |
Slc17a2 |
solute carrier family 17, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc30a10 |
solute carrier family 30, member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926781 |
|
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
associated with alcohol use disorder;DNA:deletion:promoter:-1212_-1255 (human) |
RGD |
PMID:11236836 |
RGD:36947396 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21605584 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad7 |
SMAD family member 7 |
|
ISO |
associated with hepatocellular carcinoma; mRNA:increased expression:liver (human) |
RGD |
PMID:25602745 |
RGD:14401589 |
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
IMP |
|
RGD |
PMID:22994359 |
RGD:150521663 |
NCBI chr 4:58,344,101...58,372,828
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
exacerbates |
ISO |
associated with Chemical and Drug Induced Liver Injury; |
RGD |
PMID:30097285 |
RGD:150573810 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Sod2 |
superoxide dismutase 2 |
disease_progression |
ISO |
DNA:SNP:cds:p.Ala16Val(rs1799725)(human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:32659284 PMID:19731237 |
RGD:26923907 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spag9 |
sperm associated antigen 9 |
|
ISO |
associated with Human Viral Hepatitis |
RGD |
PMID:29344208 |
RGD:30296654 |
NCBI chr10:78,943,439...79,077,797
Ensembl chr10:78,943,479...79,077,797
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23408952 |
|
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Spint1 |
serine peptidase inhibitor, Kunitz type 1 |
|
IEP |
mRNA:increased expression:spleen: |
RGD |
PMID:15086199 |
RGD:10043112 |
NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16221502 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17133483 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:22687286 |
RGD:6892914 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tagln2 |
transgelin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:23841464 |
RGD:11060135 |
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21037076 PMID:35101388 PMID:36368619 PMID:30686515 |
RGD:14985228 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
|
ISO |
|
RGD |
PMID:30686515 |
RGD:14985228 |
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28560358 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgm2 |
transglutaminase 2 |
severity treatment |
ISO |
associated with Schistosomiasis Japonica |
RGD |
PMID:31200771 PMID:31200771 |
RGD:39938956, RGD:39938956 |
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18407596 |
|
NCBI chr 3:105,056,286...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thpo |
thrombopoietin |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:9794189 |
RGD:1580082 |
Ensembl chr11:80,182,820...80,188,167
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
|
RGD |
PMID:24815695 |
RGD:15090811 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr3 |
toll-like receptor 3 |
susceptibility |
ISO |
DNA:snp: :rs3775290(human) |
RGD |
PMID:26024592 |
RGD:21079416 |
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IEP ISO |
protein:increased expression:intestine: |
RGD |
PMID:27061671 PMID:20006396 PMID:26809353 |
RGD:14697732, RGD:18182934, RGD:14700654 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19508969 |
|
NCBI chr 5:25,536,458...25,589,378
Ensembl chr 5:25,536,458...25,589,334
|
|
G |
Tnf |
tumor necrosis factor |
severity |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:19695831 |
RGD:14995448 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20353583 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25150141 |
|
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
|
|
G |
Unc93b1 |
unc-93 homolog B1, TLR signaling regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:201,167,388...201,178,343
Ensembl chr 1:201,152,693...201,178,338
|
|
G |
Ust5r |
integral membrane transport protein UST5r |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:205,210,558...205,286,868
Ensembl chr 1:205,211,034...205,286,718
|
|
G |
Vash1 |
vasohibin 1 |
treatment |
ISO |
associated with Hepatitis C, Chronic; protein:increased expression:liver |
RGD |
PMID:24390792 PMID:24390792 |
RGD:15003198, RGD:15003198 |
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
|
|
G |
Vdr |
vitamin D receptor |
severity |
ISO |
associated with nonalcoholic fatty liver disease; DNA:SNP: :rs1544410(human) |
RGD |
PMID:30683615 PMID:30218108 PMID:23622244 |
RGD:14401752, RGD:14402031, RGD:14402027 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:platelet: associated with Hepatitis C, Chronic; protein:increased expression:liver |
CTD RGD |
PMID:11981751 PMID:18544126 PMID:26627607 |
RGD:15003200, RGD:11528851 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:18544126 |
RGD:15003200 |
NCBI chr16:37,712,408...37,827,657
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:26396155 PMID:32659284 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vtn |
vitronectin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26396155 |
|
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
|
|
G |
Wdr35 |
WD repeat domain 35 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:18472094 |
RGD:11553927 |
NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
associated with Human Viral Hepatitis;DNA:missense mutation:cds:p.R399Q (rs25487) (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human) |
RGD |
PMID:24018491 PMID:29935355 PMID:23454624 |
RGD:14985244, RGD:15036797, RGD:15036794 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
susceptibility |
ISO |
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human) |
RGD |
PMID:29779728 PMID:23550892 PMID:11051375 |
RGD:14696777, RGD:15042864, RGD:15042858 |
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:16205370 |
RGD:6483345 |
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Crp |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:22441510 |
RGD:6482305 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20843640 PMID:29404441 |
RGD:14700873 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:33173221 |
RGD:151347691 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
disease_progression ameliorates |
IEP IMP |
|
RGD |
PMID:21199726 PMID:23409069 |
RGD:150429766, RGD:150517731 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset |
ISO |
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset |
RGD |
PMID:16289894 PMID:16289894 |
RGD:1578455, RGD:1578455 |
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:15566508 |
RGD:14696666 |
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver |
RGD |
PMID:24619965 |
RGD:10403061 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lep |
leptin |
|
IDA |
DNA:hypomethylation:promoter (human) |
RGD |
PMID:29912265 |
RGD:21201248 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:decreased expression:liver |
RGD |
PMID:28987423 |
RGD:14401600 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir141 |
microRNA 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Mir17 |
microRNA 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir193b |
microRNA 193b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
|
|
G |
Mir532 |
microRNA 532 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
|
|
G |
Mir93 |
microRNA 93 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
IEP |
|
RGD |
PMID:16286264 |
RGD:10043176 |
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19731237 PMID:23274713 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNP: :677C>T(human) |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IDA |
|
RGD |
PMID:19615318 |
RGD:7241800 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19946271 PMID:26482880 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:25987440 |
RGD:14696749 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Sod2 |
superoxide dismutase 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human) |
CTD RGD |
PMID:19731237 PMID:26873981 |
RGD:11060603 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:increased expression:blood, neutrophil (human) |
RGD |
PMID:18433921 |
RGD:5130706 |
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tm6sf2 |
transmembrane 6 superfamily member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26482880 |
|
NCBI chr16:19,344,218...19,351,431
Ensembl chr16:19,344,222...19,351,431
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23274713 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:20680636 |
RGD:5148026 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Edar |
ectodysplasin-A receptor |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr20:26,587,836...26,666,543
Ensembl chr20:26,587,839...26,666,494
|
|
G |
Fanci |
FA complementation group I |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:15477547 PMID:15689359 PMID:16177225 PMID:16621917 PMID:17088268 PMID:17426723 PMID:17438011 PMID:17950645 PMID:17980715 PMID:18414213 PMID:18991199 PMID:19010300 PMID:20691285 PMID:21038416 PMID:21228398 PMID:21880868 PMID:22189570 PMID:23524600 PMID:23783014 PMID:24033266 PMID:24086434 PMID:25462018 PMID:25741868 PMID:26104464 PMID:26467025 PMID:27987238 PMID:28492532 PMID:30634555 More...
|
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
susceptibility |
ISO IAGP |
DNA:mutations:cds: ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy DNA:missense mutation:cds:p.P1073L (3218C>T) (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations:cds: |
ClinVar CTD OMIM RGD |
PMID:632821 PMID:1539879 PMID:1582434 PMID:1858914 PMID:2067633 PMID:2392416 PMID:2725645 PMID:7847370 PMID:9500334 PMID:9536098 PMID:11301032 PMID:11431686 PMID:11555352 PMID:11571332 PMID:11897778 PMID:12073019 PMID:12210792 PMID:12297582 PMID:12565911 PMID:12707443 PMID:12825077 PMID:12872260 PMID:12975295 PMID:14467368 PMID:14557557 PMID:14635118 PMID:14694057 PMID:14745080 PMID:15122711 PMID:15181170 PMID:15258572 PMID:15349879 PMID:15351195 PMID:15477547 PMID:15534189 PMID:15689359 PMID:15800909 PMID:15824347 PMID:15913923 PMID:15917273 PMID:15929042 PMID:16024923 PMID:16080118 PMID:16130100 PMID:16177225 PMID:16199547 PMID:16368709 PMID:16401742 PMID:16545482 PMID:16595552 PMID:16621917 PMID:16634032 PMID:16638794 PMID:16639411 PMID:16715201 PMID:16857757 PMID:16896309 PMID:16919951 PMID:16929381 PMID:16940310 PMID:16943369 PMID:16957900 PMID:17067213 PMID:17088268 PMID:17280874 PMID:17310215 PMID:17418573 PMID:17426723 PMID:17436221 PMID:17438011 PMID:17452231 PMID:17502560 PMID:17538929 PMID:17576681 PMID:17725985 PMID:17846414 PMID:17894835 PMID:17923349 PMID:17950645 PMID:17980715 PMID:18156159 PMID:18195149 PMID:18195151 PMID:18294203 PMID:18321754 PMID:18414213 PMID:18446447 PMID:18487244 PMID:18500570 PMID:18546343 PMID:18546365 PMID:18585914 PMID:18716558 PMID:18783964 PMID:18828154 PMID:18991199 PMID:19010300 PMID:19103152 PMID:19125351 PMID:19189930 PMID:19195941 PMID:19251978 PMID:19275594 PMID:19307547 PMID:19344718 PMID:19364868 PMID:19478085 PMID:19500334 PMID:19501198 PMID:19538466 PMID:19566497 PMID:19578034 PMID:19629138 PMID:19752458 PMID:19762913 PMID:19766516 PMID:19813183 PMID:19815814 PMID:19837034 PMID:19862739 PMID:19887119 PMID:20138553 PMID:20142534 PMID:20153822 PMID:20176107 PMID:20185557 PMID:20220442 PMID:20227526 PMID:20301791 PMID:20385918 PMID:20400524 PMID:20434700 PMID:20438629 PMID:20513108 PMID:20513922 PMID:20576279 PMID:20601675 PMID:20691285 PMID:20701905 PMID:20803511 PMID:20818383 PMID:20837861 PMID:20837862 PMID:20843780 PMID:20883824 PMID:20981092 PMID:21038416 PMID:21138766 PMID:21228000 PMID:21228398 PMID:21235791 PMID:21236670 PMID:21259344 PMID:21276947 PMID:21282586 PMID:21301859 PMID:21305355 PMID:21357833 PMID:21447491 PMID:21455106 PMID:21484424 PMID:21515089 PMID:21550804 PMID:21647632 PMID:21654874 PMID:21670405 PMID:21686371 PMID:21696159 PMID:21704543 PMID:21824913 PMID:21856450 PMID:21880868 PMID:21953457 PMID:21956653 PMID:21993618 PMID:22000311 PMID:22006280 PMID:22084276 PMID:22114710 PMID:22166854 PMID:22189570 PMID:22215559 PMID:22237560 PMID:22277967 PMID:22334187 PMID:22342071 PMID:22357363 PMID:22377773 PMID:22470557 PMID:22494076 PMID:22537151 PMID:22552686 PMID:22616202 PMID:22647225 PMID:22711370 PMID:22727047 PMID:22778364 PMID:22805437 PMID:22863191 PMID:22931735 PMID:22933815 PMID:22987704 PMID:22995991 PMID:23066759 PMID:23077218 PMID:23084792 PMID:23208208 PMID:23212759 PMID:23248042 PMID:23250882 PMID:23251356 PMID:23299917 PMID:23324391 PMID:23419467 PMID:23426270 PMID:23430834 PMID:23446635 PMID:23446645 PMID:23448099 PMID:23524600 PMID:23545419 PMID:23665194 PMID:23719791 PMID:23783014 PMID:23804100 PMID:23808377 PMID:23811324 PMID:23830586 PMID:23836942 PMID:23873972 PMID:23921535 PMID:24033266 PMID:24086434 PMID:24091540 PMID:24099403 PMID:24122062 PMID:24194468 PMID:24259288 PMID:24265579 PMID:24272679 PMID:24288107 PMID:24331360 PMID:24398692 PMID:24508722 PMID:24642831 PMID:24725338 PMID:24841123 PMID:25025039 PMID:25065347 PMID:25118206 PMID:25193669 PMID:25203713 PMID:25281868 PMID:25286830 PMID:25340760 PMID:25356970 PMID:25412673 PMID:25429852 PMID:25462018 PMID:25466440 PMID:25488682 PMID:25497598 PMID:25525159 PMID:25585994 PMID:25638290 PMID:25660390 PMID:25713120 PMID:25724872 PMID:25741868 PMID:25742477 PMID:25771874 PMID:25850945 PMID:25914719 PMID:25940035 PMID:26050231 PMID:26077851 PMID:26095671 PMID:26104464 PMID:26169155 PMID:26224072 PMID:26337858 PMID:26357557 PMID:26467025 PMID:26468652 PMID:26554610 PMID:26557169 PMID:26607151 PMID:26640698 PMID:26735972 PMID:26742794 PMID:26755490 PMID:26942291 PMID:26942292 PMID:26968897 PMID:27016405 PMID:27111573 PMID:27119776 PMID:27185166 PMID:27271921 PMID:27290639 PMID:27345795 PMID:27349602 PMID:27381400 PMID:27422324 PMID:27450679 PMID:27475922 PMID:27538604 PMID:27538665 PMID:27822509 PMID:27826120 PMID:27838477 PMID:27843123 PMID:27987238 PMID:28074849 PMID:28128857 PMID:28130605 PMID:28154168 PMID:28206745 PMID:28337550 PMID:28430993 PMID:28444220 PMID:28471437 PMID:28480171 PMID:28492532 PMID:28634151 PMID:28771251 PMID:28776642 PMID:28812649 PMID:28815208 PMID:28837072 PMID:28865037 PMID:28901595 PMID:28958595 PMID:29029963 PMID:29190809 PMID:29272804 PMID:29278894 PMID:29302508 PMID:29341116 PMID:29358615 PMID:29423831 PMID:29431110 PMID:29474836 PMID:29482223 PMID:29574624 PMID:29588995 PMID:29644085 PMID:29655203 PMID:29712893 PMID:29915382 PMID:29920680 PMID:29950568 PMID:29992832 PMID:30021052 PMID:30167885 PMID:30255931 PMID:30290626 PMID:30306720 PMID:30369941 PMID:30373890 PMID:30385167 PMID:30404819 PMID:30423451 PMID:30451971 PMID:30487145 PMID:30609409 PMID:30634555 PMID:30637288 PMID:30678510 PMID:30755392 PMID:30818899 PMID:30831263 PMID:30838265 PMID:30843307 PMID:30860128 PMID:30936349 PMID:30941926 PMID:30951992 PMID:31085725 PMID:31147703 PMID:31164858 PMID:31425757 PMID:31475037 PMID:31521625 PMID:31571979 PMID:31589614 PMID:31613174 PMID:31645654 PMID:31655921 PMID:31658717 PMID:31665838 PMID:31669236 PMID:31731261 PMID:31762033 PMID:31980526 PMID:31996268 PMID:32005694 PMID:32019516 PMID:32042919 PMID:32161153 PMID:32234506 PMID:32347949 PMID:32348839 PMID:32445240 PMID:32502631 PMID:32504279 PMID:32567010 PMID:32600829 PMID:32703289 PMID:32964447 PMID:33233646 PMID:33258288 PMID:33278787 PMID:33396418 PMID:33434755 PMID:33469851 PMID:33473333 PMID:33486010 PMID:33579567 PMID:33600046 PMID:33671400 PMID:33726816 PMID:33791913 PMID:34008892 PMID:34194468 PMID:34690748 PMID:34782754 PMID:35307828 PMID:15689359 PMID:20142534 PMID:16896309 PMID:22237560 More...
|
RGD:8694184, RGD:15039298, RGD:8694317, RGD:8694284 |
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Polrmt |
RNA polymerase mitochondrial |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:25741868 |
|
NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791
|
|
G |
Ranbp2 |
RAN binding protein 2 |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr20:26,442,156...26,493,481
Ensembl chr20:26,442,217...26,493,481
|
|
G |
Rlbp1 |
retinaldehyde binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:2392416 PMID:11301032 PMID:21447491 PMID:25429852 PMID:28492532 |
|
NCBI chr 1:133,308,920...133,322,296
Ensembl chr 1:133,308,938...133,322,296
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:21290180 |
RGD:25671452 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
DNA:missense mutation: :p.L33P (human) |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility |
ISO |
DNA:polymorphism:promoter: |
RGD |
PMID:18685811 |
RGD:10755472 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
associated with Polycystic Kidney, Autosomal Recessive;mRNA:increased expression:liver |
RGD |
PMID:20400910 |
RGD:2325215 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ifnl3 |
interferon, lambda 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28394349 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
DNA:mutations:cds:c.7994T>C, p.(Leu2665Pro),c.8518C>T, p.(Arg2840Cys)(human) |
RGD |
PMID:30600684 PMID:30507656 |
RGD:14700919, RGD:14700992 |
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
|
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
susceptibility |
ISO |
DNA:SNP: :-318C>T(human) |
RGD |
PMID:18049163 |
RGD:14398738 |
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
ClinVar Annotator: match by term: Cirrhosis, cryptogenic |
ClinVar |
PMID:9011570 PMID:12724528 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
ClinVar Annotator: match by term: Cirrhosis, cryptogenic |
ClinVar |
PMID:9011570 PMID:11372009 PMID:12724528 PMID:15235035 PMID:33116287 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aadat |
aminoadipate aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16182555 PMID:17072980 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500
|
|
G |
Ace |
angiotensin I converting enzyme |
severity |
IEP |
mRNA: increased expression:liver (rat) protein:increased activity:plasma (human) mRNA:increased expression:liver (rat) |
RGD |
PMID:19424597 PMID:8445218 PMID:23663763 PMID:24035938 |
RGD:25671449, RGD:25671458, RGD:25671457, RGD:21408579 |
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
IEP |
protein:increased expression:liver mRNA, protein:increased expression, increased activity:liver (rat) |
RGD |
PMID:19793108 PMID:16166274 |
RGD:2316776, RGD:40818265 |
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16496349 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism associated with Schistosomiasis Japonica; mRNA:increased expression:liver (rat) |
CTD RGD |
PMID:26435214 PMID:26739621 PMID:29323718 |
RGD:38599216 |
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actn1 |
actinin, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Add3 |
adducin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:14724832 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
ISO |
|
RGD |
PMID:29237572 |
RGD:24922203 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adm |
adrenomedullin |
|
IEP ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15370692 PMID:16610064 PMID:16713642 |
RGD:1625319 |
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16783407 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adora3 |
adenosine A3 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr 1:255,772,217...255,773,617
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:19785950 |
RGD:5129118 |
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
|
|
G |
Aen |
apoptosis enhancing nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Afm |
afamin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:17,531,026...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Afp |
alpha-fetoprotein |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17072980 PMID:30346985 |
RGD:151665755 |
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:84,124,878...84,178,149
Ensembl chr 9:84,125,120...84,178,128
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12667390 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12890498 PMID:25380136 PMID:24619965 |
RGD:10403061 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahnak |
AHNAK nucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Aida |
axin interactor, dorsalization associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:94,940,311...94,967,920
Ensembl chr13:94,939,741...94,967,920
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
AKR1C3l1 |
aldo-keto reductase family 1 member C3-like 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr17:65,847,580...65,881,488
Ensembl chr17:65,835,634...65,881,488
|
|
G |
Aktip |
AKT interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:15,866,811...15,877,123
Ensembl chr19:15,866,928...15,886,663
|
|
G |
Alb |
albumin |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16642209 PMID:17963606 PMID:21163135 PMID:30346985 |
RGD:151665755 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 PMID:25380136 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:20,254,196...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15650968 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Angpt1 |
angiopoietin 1 |
disease_progression |
IEP |
protein:increased expression:liver |
RGD |
PMID:17935226 |
RGD:1643338 |
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
mRNA, protein:increased expression:multiple organs (rat) |
RGD |
PMID:18978178 |
RGD:2314174 |
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Angptl3 |
angiopoietin-like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Ano6 |
anoctamin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:126,933,629...127,113,589
Ensembl chr 7:126,933,936...127,113,589
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
treatment |
ISO |
|
RGD |
PMID:19054144 |
RGD:10401133 |
NCBI chr 8:62,829,125...62,864,469
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa1 |
annexin A1 |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:8755646 |
RGD:2306954 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa3 |
annexin A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
|
|
G |
Ap3s1 |
adaptor related protein complex 3 subunit sigma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:39,462,727...39,531,626
Ensembl chr18:39,462,765...39,531,622
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apbb1ip |
amyloid beta precursor protein binding family B member 1 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:139,409,020...139,437,296
Ensembl chr 3:139,409,022...139,437,341
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
IDA |
|
RGD |
PMID:2123716 |
RGD:1599161 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
|
|
G |
Apol9a |
apolipoprotein L 9a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Arg1 |
arginase 1 |
|
IEP |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:11931836 |
RGD:1626298 |
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:11931836 |
RGD:1626298 |
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap30 |
Rho GTPase activating protein 30 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:83,822,290...83,843,634
Ensembl chr13:83,822,283...83,854,885
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arl11 |
ADP-ribosylation factor like GTPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:35,483,330...35,485,579
Ensembl chr15:35,480,018...35,496,596
|
|
G |
Arl8a |
ADP-ribosylation factor like GTPase 8A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:46,585,845...46,594,851
Ensembl chr13:46,585,845...46,594,851
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspn |
asporin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
|
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:19914391 |
RGD:4140452 |
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:97,656,725...97,672,211
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Atrn |
attractin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Axl |
Axl receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B2m |
beta-2 microglobulin |
|
IEP |
protein:increased expression:urine |
RGD |
PMID:18777138 |
RGD:6482712 |
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
|
|
G |
B9d1 |
B9 domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:11232245 |
RGD:2315709 |
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IDA IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24218972 PMID:17938867 |
RGD:10054116, RGD:2293129 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:13,471,679...13,596,497
Ensembl chr20:13,471,668...13,597,016
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bgn |
biglycan |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:15,259,773...15,304,889
Ensembl chr17:15,259,773...15,304,889
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP |
|
RGD |
PMID:17938867 |
RGD:2293129 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
|
|
G |
Blvra |
biliverdin reductase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Bmf |
Bcl2 modifying factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:16447265 |
RGD:1643229 |
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17127702 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
C11h3orf70 |
similar to human chromosome 3 open reading frame 70 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:79,345,792...79,396,140
Ensembl chr11:79,345,304...79,396,142
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qb |
complement C1q B chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1qc |
complement C1q C chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C5ar1 |
complement C5a receptor 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:15995705 |
RGD:1600592 |
NCBI chr 1:76,948,622...76,959,826
|
|
G |
C7 |
complement C7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8g |
complement C8 gamma chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:8,320,495...8,323,495
Ensembl chr 3:8,305,920...8,323,495
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Capg |
capping actin protein, gelsolin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Car3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car5a |
carbonic anhydrase 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:16092975 |
RGD:2311470 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp4 |
caspase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism human gene in rat model |
CTD RGD |
PMID:15492853 PMID:19144177 PMID:28437891 PMID:15492853 |
RGD:2307001, RGD:14995945, RGD:8549576 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment disease_progression severity |
ISO |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver |
CTD RGD |
PMID:25380136 PMID:22574195 PMID:25617348 PMID:20978355 PMID:20978355 |
RGD:14995337, RGD:14995329, RGD:14995328, RGD:14995328 |
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
IEP |
|
RGD |
PMID:17719030 |
RGD:6483766 |
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
IEP ISO |
mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:19856102 |
RGD:2314367 |
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn4 |
cellular communication network factor 4 |
|
IEP |
|
RGD |
PMID:24600972 |
RGD:10003105 |
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna2 |
cyclin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb2 |
cyclin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
ISO |
mRNA,protein:increased expression:liver |
RGD |
PMID:19603542 PMID:19603542 |
RGD:14401743, RGD:14401743 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd200r1 |
CD200 receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:55,886,937...55,921,217
Ensembl chr11:55,887,717...55,921,285
|
|
G |
Cd24 |
CD24 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd276 |
Cd276 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd38 |
CD38 molecule |
|
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:16343077 |
RGD:2307239 |
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd48 |
Cd48 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd53 |
Cd53 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:194,352,139...194,399,668
Ensembl chr 2:194,352,139...194,399,657
|
|
G |
Cd5l |
Cd5 molecule-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd63 |
Cd63 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd7 |
Cd7 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:106,304,046...106,306,963
Ensembl chr10:106,304,056...106,306,967
|
|
G |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd83 |
CD83 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdh1 |
cadherin 1 |
|
IEP |
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat) |
RGD |
PMID:29323718 |
RGD:38599216 |
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh5 |
cadherin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
|
IEP |
|
RGD |
PMID:16534847 |
RGD:2289284 |
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
IEP |
|
RGD |
PMID:16534847 |
RGD:2289284 |
NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
|
|
G |
Cerk |
ceramide kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Ces2h |
carboxylesterase 2H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Ces3a |
carboxylesterase 3a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfd |
complement factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cfp |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:119,689,626...119,750,711
Ensembl chr 1:119,686,350...119,750,601
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cklf |
chemokine-like factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570
|
|
G |
Clec4a1 |
C-type lectin domain family 4, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Clic1 |
chloride intracellular channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clic2 |
chloride intracellular channel 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
|
|
G |
Clp1 |
cleavage factor polyribonucleotide kinase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cndp1 |
carnosine dipeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cnpy4 |
canopy FGF signaling regulator 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:17,064,642...17,070,755
Ensembl chr12:17,064,642...17,070,043
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17043671 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
treatment |
IEP ISO IDA IMP |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (rat) |
CTD RGD |
PMID:25380136 PMID:26435214 PMID:26739621 PMID:16009107 PMID:30346985 PMID:22706148 PMID:23958495 PMID:20818932 More...
|
RGD:1601595, RGD:151665755, RGD:8552768, RGD:8552710, RGD:5688339 |
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:7512265 |
RGD:7257544 |
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11788567 PMID:25380136 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
|
IEP ISO |
Protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:7791542 |
RGD:1600938 |
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Colec12 |
collectin sub-family member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Coq10a |
coenzyme Q10A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cpq |
carboxypeptidase Q |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
IEP ISO |
mRNA:decreased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15650968 PMID:17539997 |
RGD:2303515 |
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crot |
carnitine O-octanoyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:decreased expression:serum: |
RGD |
PMID:21806828 |
RGD:9491781 |
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Crtap |
cartilage associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:114,047,929...114,067,648
Ensembl chr 8:114,047,933...114,067,631
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cryab |
crystallin, alpha B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15661404 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Ctss |
cathepsin S |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Ctsz |
cathepsin Z |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
|
|
G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:16,982,752...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cygb |
cytoglobin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581302 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
treatment |
IMP |
|
RGD |
PMID:15521018 |
RGD:15045602 |
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
|
|
G |
Cyrib |
CYFIP related Rac1 interactor B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:95,633,876...95,760,588
Ensembl chr 7:95,633,876...95,697,686
|
|
G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:27,945,862...28,013,509
Ensembl chr18:27,951,653...28,013,510
|
|
G |
Dag1 |
dystroglycan 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:12177244 |
RGD:2314895 |
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
|
|
G |
Dao |
D-amino-acid oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dbh |
dopamine beta-hydroxylase |
|
IEP |
mRNA:decreased expression:superior mesenteric artery (rat) |
RGD |
PMID:18457899 |
RGD:5129683 |
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dbndd2 |
dysbindin domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:153,193,213...153,220,651
Ensembl chr 3:153,191,090...153,220,651
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:106,006,404...106,008,294
|
|
G |
Ddc |
dopa decarboxylase |
|
IEP ISO |
mRNA:decreased expression:superior mesenteric artery (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25380136 PMID:18457899 |
RGD:5129683 |
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Depdc7 |
DEP domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
|
|
G |
Dock10 |
dedicator of cytokinesis 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
|
|
G |
Dock7 |
dedicator of cytokinesis 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:113,599,371...113,782,871
Ensembl chr 5:113,600,198...113,782,813
|
|
G |
Dpp7 |
dipeptidylpeptidase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:8,165,091...8,169,343
Ensembl chr 3:8,165,091...8,169,355
|
|
G |
Dpys |
dihydropyrimidinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dram1 |
DNA-damage regulated autophagy modulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
|
|
G |
Dus1l |
dihydrouridine synthase 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:106,055,519...106,062,656
Ensembl chr10:106,055,519...106,062,781
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:167,546,780...167,629,949
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dysf |
dysferlin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:16170464 |
RGD:7243952 |
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Ect2 |
epithelial cell transforming 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12609069 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eeig2 |
EEIG family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif4e3 |
eukaryotic translation initiation factor 4E family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:78,790,799...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Emb |
embigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Emp1 |
epithelial membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Enpep |
glutamyl aminopeptidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
treatment |
IEP ISO |
protein:increased activity:serum: CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17072980 PMID:17850827 PMID:20957682 |
RGD:9685426, RGD:9685427 |
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
IEP |
|
RGD |
PMID:15651265 |
RGD:9685530 |
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Epcam |
epithelial cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Extl1 |
exostosin-like glycosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
|
|
G |
Ezr |
ezrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F5 |
coagulation factor V |
treatment |
IEP |
|
RGD |
PMID:17431769 |
RGD:7394781 |
NCBI chr13:76,513,463...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:211,040,032...211,044,089
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
|
|
G |
Fam167b |
family with sequence similarity 167, member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:141,920,695...141,922,342
Ensembl chr 5:141,920,695...141,922,340
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr19:52,710,003...52,722,591
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:30737368 PMID:17105443 |
RGD:2290284 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxo9 |
f-box protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:83,649,447...83,654,215
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
|
|
G |
Fcnb |
ficolin B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:11,393,771...11,402,198
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16116963 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
treatment |
IMP |
|
RGD |
PMID:21543745 |
RGD:25440477 |
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
mRNA:increased expression |
RGD |
PMID:17054587 |
RGD:1599810 |
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgl2 |
fibrinogen-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:45,388,979...45,462,530
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fli1 |
Fli-1 proto-oncogene, ETS transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
|
|
G |
Flna |
filamin A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Fmnl1 |
formin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:88,115,876...88,143,342
Ensembl chr10:88,116,009...88,143,357
|
|
G |
Fmnl2 |
formin-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 PMID:25380136 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fn1 |
fibronectin 1 |
treatment |
IEP IMP |
mRNA:increased expression:liver: mRNA:altered expression:liver (rat) |
RGD |
PMID:19914391 PMID:15980055 |
RGD:4140452, RGD:1625201 |
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Folr2 |
folate receptor beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa2 |
forkhead box A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxo1 |
forkhead box O1 |
|
IEP |
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat) |
RGD |
PMID:29323718 |
RGD:38599216 |
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fry |
FRY microtubule binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fstl1 |
follistatin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:45,712,887...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Fzd8 |
frizzled class receptor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
|
|
G |
G0s2 |
G0/G1switch 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
|
ISO |
protein:increased tyrosine phosphorylation: : |
RGD |
PMID:25617348 |
RGD:14995329 |
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
|
|
G |
Galc |
galactosylceramidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
|
|
G |
Gask1b |
golgi associated kinase 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gbp2 |
guanylate binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gbp4 |
guanylate binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gcat |
glycine C-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gck |
glucokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
|
|
G |
Get1 |
guided entry of tail-anchored proteins factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
|
|
G |
Gfap |
glial fibrillary acidic protein |
|
IEP |
associated with Schistosomiasis Japonica; mRNA:decreased expression:liver (rat) |
RGD |
PMID:29323718 |
RGD:38599216 |
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ggta1 |
glycoprotein alpha-galactosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:18,732,991...18,809,908
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15334695 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghr |
growth hormone receptor |
|
IEP ISO |
mRNA, protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17072980 PMID:25380136 PMID:12679928 |
RGD:2307378 |
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gk |
glycerol kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Gls |
glutaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Gls2 |
glutaminase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Gmfg |
glia maturation factor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gna14 |
G protein subunit alpha 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gngt2 |
G protein subunit gamma transducin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr10:80,776,003...80,784,235
|
|
G |
Gnpda1 |
glucosamine-6-phosphate deaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17072980 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25380136 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpnmb |
glycoprotein nmb |
|
| |